Literature DB >> 30365908

Basics of CD8 T-cell immune responses after influenza infection and vaccination with inactivated or live attenuated influenza vaccine.

Daniil Korenkov1, Irina Isakova-Sivak1, Larisa Rudenko1.   

Abstract

INTRODUCTION: One of the essential mechanisms of virus infection control is cell-mediated cytotoxicity, which can act in an antibody-dependent or -independent fashion and is provided by different effector cells. The role of CD8 T-cells in infection control and in affecting the pathological outcome of different types of infection has been demonstrated in numerous animal studies. Despite this, their role in controlling human influenza infection is not fully understood. Especially, knowledge about their induction and turnover in human influenza infection is limited. Differences in the development of CD8 T-cells after influenza infection or immunizations should be explored in detail, in relation to the bioaccessibility of influenza antigens, site of application and distribution routes. AREAS COVERED: This review focuses on the basics of CD8 T-cell immune response both in human influenza infection and after administration of inactivated or live attenuated influenza vaccine. Some aspects of the accessibility, distribution and presentation of influenza antigens to CD8 T-cells are described. EXPERT COMMENTARY: The CD8 T-cell response is an essential connection between innate and antibody-mediated responses, which are all-important for influenza control. We hypothesize that immunization with live influenza vaccine is the most straightforward artificial way to induce an efficient influenza-specific CD8 T-cell response.

Entities:  

Keywords:  CD8 T lymphocytes; humans; influenza; vaccines

Mesh:

Substances:

Year:  2018        PMID: 30365908     DOI: 10.1080/14760584.2018.1541407

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  20 in total

1.  Postvaccination graft dysfunction/aplastic anemia relapse with massive clonal expansion of autologous CD8+ lymphocytes.

Authors:  Caitlin Ritz; Wenzhao Meng; Natasha L Stanley; Miren L Baroja; Chong Xu; Patrick Yan; Alexander C Huang; Ryan Hausler; Peter Nicholas; Jian-Meng Fan; David Lieberman; Beatriz M Carreno; Eline T Luning Prak; Timothy S Olson; Daria V Babushok
Journal:  Blood Adv       Date:  2020-04-14

2.  Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease.

Authors:  Tatiana Kotomina; Irina Isakova-Sivak; Victoria Matyushenko; Ki-Hye Kim; Youri Lee; Yu-Jin Jung; Sang-Moo Kang; Larisa Rudenko
Journal:  Antiviral Res       Date:  2019-05-07       Impact factor: 5.970

3.  Human influenza virus challenge identifies cellular correlates of protection for oral vaccination.

Authors:  David R McIlwain; Han Chen; Zainab Rahil; Neda Hajiakhoond Bidoki; Sizun Jiang; Zach Bjornson; Nikita S Kolhatkar; C Josefina Martinez; Brice Gaudillière; Julien Hedou; Nilanjan Mukherjee; Christian M Schürch; Angelica Trejo; Melton Affrime; Bonnie Bock; Kenneth Kim; David Liebowitz; Nima Aghaeepour; Sean N Tucker; Garry P Nolan
Journal:  Cell Host Microbe       Date:  2021-11-15       Impact factor: 21.023

4.  Dynamic causal modelling of immune heterogeneity.

Authors:  Thomas Parr; Anjali Bhat; Peter Zeidman; Aimee Goel; Alexander J Billig; Rosalyn Moran; Karl J Friston
Journal:  Sci Rep       Date:  2021-05-31       Impact factor: 4.379

5.  Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized memory T cells and augment influenza-specific resident memory T-cell responses.

Authors:  Victoria Matyushenko; Tatiana Kotomina; Igor Kudryavtsev; Daria Mezhenskaya; Polina Prokopenko; Anastasia Matushkina; Konstantin Sivak; Arman Muzhikyan; Larisa Rudenko; Irina Isakova-Sivak
Journal:  Antiviral Res       Date:  2020-06-22       Impact factor: 5.970

Review 6.  African swine fever vaccines: a promising work still in progress.

Authors:  Laia Bosch-Camós; Elisabeth López; Fernando Rodriguez
Journal:  Porcine Health Manag       Date:  2020-07-02

7.  Systemic and respiratory T-cells induced by seasonal H1N1 influenza protect against pandemic H2N2 in ferrets.

Authors:  Koen van de Ven; Femke de Heij; Harry van Dijken; José A Ferreira; Jørgen de Jonge
Journal:  Commun Biol       Date:  2020-10-09

Review 8.  Pollution, Inflammation, and Vaccines: A Complex Crosstalk.

Authors:  Laura Franza; Rossella Cianci
Journal:  Int J Environ Res Public Health       Date:  2021-06-11       Impact factor: 3.390

9.  An Inactivated Influenza Virus Vaccine Approach to Targeting the Conserved Hemagglutinin Stalk and M2e Domains.

Authors:  Weina Sun; Allen Zheng; Robert Miller; Florian Krammer; Peter Palese
Journal:  Vaccines (Basel)       Date:  2019-09-18

Review 10.  Recent advances in influenza vaccines.

Authors:  Graham Pawelec; Janet McElhaney
Journal:  F1000Res       Date:  2020-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.